IDNA vs. CNCR ETF Comparison
Comparison of iShares Genomics Immunology and Healthcare ETF (IDNA) to Loncar Cancer Immunotherapy ETF (CNCR)
IDNA
iShares Genomics Immunology and Healthcare ETF
IDNA Description
The investment seeks to track the investment results of the NYSE FactSet Global Genomics and Immuno Biopharma Index. The fund generally will invest at least 90% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 10% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.
Grade (RS Rating)
Last Trade
$23.30
Average Daily Volume
29,488
34
CNCR
Loncar Cancer Immunotherapy ETF
CNCR Description
ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.Grade (RS Rating)
Last Trade
$13.25
Average Daily Volume
3,715
67
Performance
| Period | IDNA | CNCR |
|---|---|---|
| 30 Days | -4.54% | -10.65% |
| 60 Days | -6.96% | -14.47% |
| 90 Days | -6.02% | -9.20% |
| 12 Months | 17.65% | 30.29% |
13 Overlapping Holdings
| Symbol | Grade | Weight in IDNA | Weight in CNCR | Overlap | |
|---|---|---|---|---|---|
| ACLX | C | 4.42% | 1.73% | 1.73% | |
| BPMC | C | 1.46% | 1.58% | 1.46% | |
| EXEL | B | 6.44% | 1.9% | 1.9% | |
| GERN | C | 2.18% | 1.31% | 1.31% | |
| IOVA | F | 2.38% | 1.3% | 1.3% | |
| MGNX | D | 0.26% | 1.55% | 0.26% | |
| MRK | F | 2.97% | 1.24% | 1.24% | |
| NRIX | C | 1.69% | 1.29% | 1.29% | |
| RCUS | F | 0.88% | 1.29% | 0.88% | |
| REGN | F | 3.22% | 1.0% | 1.0% | |
| RVMD | B | 5.78% | 1.84% | 1.84% | |
| SWTX | C | 2.39% | 1.47% | 1.47% | |
| XNCR | B | 0.35% | 1.66% | 0.35% |
IDNA Overweight 21 Positions Relative to CNCR
IDNA Underweight 54 Positions Relative to CNCR
| Symbol | Grade | Weight | |
|---|---|---|---|
| GLUE | C | -2.03% | |
| BMY | B | -1.72% | |
| ELVN | C | -1.68% | |
| MRSN | C | -1.62% | |
| KPTI | D | -1.57% | |
| REPL | C | -1.56% | |
| GNLX | D | -1.56% | |
| HCM | C | -1.54% | |
| CRBU | D | -1.47% | |
| JANX | C | -1.46% | |
| ERAS | C | -1.46% | |
| DAWN | D | -1.44% | |
| IMCR | C | -1.42% | |
| RXRX | D | -1.39% | |
| SDGR | C | -1.39% | |
| ARVN | F | -1.39% | |
| AURA | C | -1.38% | |
| LYEL | F | -1.35% | |
| SNDX | F | -1.34% | |
| MRUS | F | -1.33% | |
| KYMR | D | -1.32% | |
| RPTX | F | -1.32% | |
| FHTX | C | -1.26% | |
| NUVB | C | -1.26% | |
| BNTX | D | -1.25% | |
| ZNTL | D | -1.25% | |
| BCYC | F | -1.24% | |
| YMAB | F | -1.24% | |
| BMEA | F | -1.22% | |
| PGEN | F | -1.2% | |
| CGEM | F | -1.2% | |
| ALLO | F | -1.18% | |
| NUVL | D | -1.18% | |
| VOR | D | -1.17% | |
| GMAB | F | -1.17% | |
| TYRA | F | -1.16% | |
| KURA | F | -1.16% | |
| ACRV | F | -1.15% | |
| AUTL | F | -1.13% | |
| STRO | F | -1.12% | |
| LEGN | D | -1.1% | |
| IDYA | F | -1.07% | |
| TSVT | F | -1.06% | |
| ITOS | F | -0.98% | |
| IPHA | F | -0.98% | |
| SMMT | D | -0.97% | |
| ACET | F | -0.97% | |
| IMRX | F | -0.95% | |
| IMTX | F | -0.93% | |
| RLAY | F | -0.91% | |
| IGMS | F | -0.88% | |
| RAPT | F | -0.88% | |
| FATE | F | -0.87% | |
| PRLD | F | -0.55% |
IDNA: Top Represented Industries & Keywords
CNCR: Top Represented Industries & Keywords
Compare ETFs
